<DOC>
	<DOCNO>NCT01145885</DOCNO>
	<brief_summary>Investigation absorption , distribution , metabolism excretion ( ADME ) assessment safety , tolerability preliminary therapeutic effect [ 14C ] volasertib patient advance solid tumour .</brief_summary>
	<brief_title>BI 6727 ( Volasertib ) Human ADME Trial Various Solid Tumours</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Inclusion Criteria 1 . Patients histologically cytologically confirm diagnosis advance , non resectable / metastatic solid tumour Inclusion Criteria 2 . Male Inclusion Criteria 3 . Age &gt; =18 = &lt; 70 year Inclusion Criteria 4 . Written inform consent Inclusion Criteria 5 . Eastern Cooperative Oncology Group ( ECOG ) performance score = &lt; 2 Inclusion Criteria 6 . Recovery Common Terminology Criteria Adverse Events ( CTCAE ) Grade &gt; =2 therapyrelated toxicity previous chemo , hormone , immuno , radiotherapy Exclusion criterion : Exclusion Criteria 1 . Serious concomitant nononcological disease consider investigator Exclusion Criteria 2 . Active infectious disease Exclusion Criteria 3 . Viral hepatitis , Human Immunodeficiency Virus ( HIV ) infection Exclusion Criteria 4 . Clinical evidence active brain metastasis past 6 month Exclusion Criteria 5 . Second malignancy currently require active therapy Exclusion Criteria 6 . Absolute neutrophil count le 1,500/mm3 Exclusion Criteria 7 . Platelet count le 100,000/mm3 Exclusion Criteria 8 . Total bilirubin great 1.5 mg/dL Exclusion Criteria 9 . Aspartate amino transferase ( AST ) / alanine amino transferase ( ALT ) great 2.5 time upper limit normal ( related liver metastasis great five time upper limit normal ) Exclusion Criteria 10 . Serum creatinine great 1.5x Upper Limit Normal ( ULN ) . Exclusion Criteria 11 . Known history QT/QTcFprolongation Exclusion Criteria 12 . Patients sexually active partner childbearing potential unwilling use medically acceptable method contraception Exclusion Criteria 13 . Treatment investigational drug participation another clinical trial Exclusion Criteria 14 . Chemo , radio immuno , moleculartargeted cancertherapy within past four week prior start therapy concomitantly trial . This restriction apply steroids bisphosphonates . Exclusion Criteria 15 . Alcohol abuse Exclusion Criteria 16 . Life expectancy le 12 week Exclusion Criteria 17 . Potent Cytochrome P450 enzyme ( CYP ) 3A4 Pglycoprotein inhibitor inducer Exclusion Criteria 18 . History allergy/hypersensitivity</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>